期刊文献+

肝癌切除术前无创性门脉高压评估进展 被引量:1

下载PDF
导出
摘要 原发性肝癌及门脉高压是都是肝硬化的重要并发症,对于肝功能正常或者肝硬化代偿的肝癌患者,手术切除为首选治疗。可是,门脉高压可能会诱发肝癌切除术后患者腹腔或消化道出血、肝功能衰竭等并发症,甚至导致患者死亡。因此,术前精确评估门脉压力,对于保障手术安全显得尤为重要。
出处 《肝胆外科杂志》 2013年第3期233-236,共4页 Journal of Hepatobiliary Surgery
基金 上海市科委医学引导项目<肝脏切除术手术预测模型>(项目编号:114119a7800)
  • 相关文献

参考文献40

  • 1Stremitzer S,Tamandl D, et al. Value of hepatic venous pressuregradient measurement before liver resection for hepatocellular carcino-ma. British Journal of Surgery 2011 ; 98 : 1752 - 1758.
  • 2Blanchet L,Lebrec D. Changes in splanchnic blood flow in portal hy-pertensive rats. Eur J Clin Invest 1982; 12:327 - 330.
  • 3Valla D,Poynard T, Bercofi E,Bataille C, Goldfarb G, Lebrec D.Systemic circulatory syndrome in patients with cirrhosis. Relationshipwith hepatocellular failure and portal hypertension. Gastroenterol ClinBiol 1984 ;8 :321 -324.
  • 4Choi YJ, Baik SK, Park DH,Kim MY, Kim HS, Lee DK, el al.Comparison of Doppler ultrasonography and the hepatic venous pres-sure gradient in assessing portal hypertension in liver cirrhosis. JGastroenterol Hepatol 2003 ;18 :424 -429.
  • 5Hasegawa T,Kimura T, Sasaki T, and Okada A,“ Plasma endothe-lin — 1 level as a marker reflecting the severity of portal hypertensionin biliary atresia,M Journal of Pediatric Surgery, vol. 36, no. 11,pp. 1609 -1612, 2001.
  • 6Pawar R, Kemp W , Roberts S, Krum H, Yandle T, and HardikarW, “Urotensin II levels are an important marker for the severity ofportal hypertension in children,” Journal of Pediatric Gastroenterolo-gy and Nutrition, vol. 53,no. 1,pp. 88 -92 , 2011.
  • 7P. Vallance and J. Leiper, “Cardiovascular biology of the asymmet-ric dimethylarginine : dimethylarginine dimethylaminohydrolase path-way ,Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24,no. 6,pp. 1023 -1030,2004.
  • 8P. Lluch, B. Torondel, P. Medina et al.,“Plasma concentrations ofnitric oxide and asymmetric dimethylarginine in human alcoholic cir-rhosis ,M Journal of Hepatology, vol. 41, no. 1,pp. 55 - 59,2004.
  • 9F. Vizzutti, R. G. Romanelli, U. Arena et al.,“ADMA correlateswith portal pressure in patients with compensated cirrhosis, ” Europe-an Journal of Clinical Investigation, vol. 37, no. 6,pp. 509 -515,2007.
  • 10S. S. Abdelmoneim, J. Talwalkar,S. Sethi et al. , “A prospectivepilot study of circulating endothelial cells as a potential new biomark-er in portal hypertension,” Liver International, vol. 30,no. 2,pp.191 - 197,2010.

同被引文献5

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部